Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Briers

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Urology|October 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate CancerPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
European Urology Oncology|December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate CancerFinbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
European Urology|April 13, 2024
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|April 30, 2024
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate CancerDerya Tilki, Roderick C N van den Bergh, Erik Briers, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
European Urology Focus|May 10, 2021
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisMichael Lardas, Nikos Grivas, Thomas P A Debray, et al.
European Urology Oncology|January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further ResearchAnthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.
European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
European Urology|April 28, 2023
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic ReviewGiancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Urology|October 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate CancerPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
European Urology Oncology|December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate CancerFinbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
European Urology|April 13, 2024
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|April 30, 2024
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate CancerDerya Tilki, Roderick C N van den Bergh, Erik Briers, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
European Urology Focus|May 10, 2021
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysisMichael Lardas, Nikos Grivas, Thomas P A Debray, et al.
European Urology Oncology|January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further ResearchAnthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.
European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
European Urology|April 28, 2023
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic ReviewGiancarlo Marra, Geert J L H van Leenders, Fabio Zattoni, et al.
Pageof 5